ACSS3 and type 1 diabetes mellitus: Using HCQ that is under clinical trial for the prevention of glucose tolerance of T1D patients (NIDDK, NCT03428945), we treated WT and Acss3–/– mice with HCQ (0.15 mmol/L in drinking water) under normal diet and HFD.